From: Factors that influence survival in a probable Alzheimer disease cohort
Variable (n = 641) | Value | Percentage | Range |
---|---|---|---|
Age, years | 73.0 (8.50) | Â | 43-93 |
Female | Â | 68 | Â |
Race (white versus non-white) | Â | 87 | Â |
Education, years | 14.0 (3.56) | Â | 0-29 |
Duration of symptoms before initial visit, years | 3.7 (2.29) | Â | 0.5-13 |
Follow-up time from baseline to censoring or death, years | 3.0 (1.94) | Â | 0.7-13.4 |
Total number of follow-up visits to the clinic | 2.4 (1.64) | Â | 2-11 |
MMSE score | 19.5 (6.64) | Â | 0-30 |
PSMS score | 7.9 (3.05) | Â | 6-25 |
Using antipsychotics drugs | 221 | 34.5 | Â |
Using antidementia drugs | 554 | 86.4 | Â |
Pre-progression rate | Â | Â | Â |
   Slow | 192 | 30.0 |  |
   Moderate | 297 | 46.3 |  |
   Fast | 152 | 23.7 |  |
Experiencing hallucination | 291 | 45.4 | Â |
Experiencing delusions | 371 | 57.9 | Â |